• EyeGate® II Delivery System
• Our Strategy
• Management
• Board of Directors
• Scientific Advisory Board

Scientific Advisory Board

C. Stephen Foster, M.D., Founder and Director of the Massachusetts Eye Research and Surgery Institute (MERSI), Clinical Professor of Ophthalmology at Harvard Medical School and Founder and President of the Ocular Immunology and Uveitis Foundation. He created the Ocular Immunology and Uveitis Service at the Massachusetts Eye and Ear Infirmary in 1980 and founded a Fellowship training program in 1984 (over 100 ophthalmologists have completed training). He is the author of over 500 published books and papers and has won numerous awards including The International Ocular Inflammation Society Award and The American Academy of Ophthalmology Senior Honor Award and has been repeatedly listed in America's Top Doctors: Castle Connolly Medial Ltd. and Best Doctors in America. He was originally trained at the Duke University School of Medicine.

Michael Raizman, M.D., Ophthalmic Consultants of Boston, he also an Assoc Prof of Ophthalmology at Tufts University School of Medicine. He is on the editorial board of the Archives of Ophthalmology and Therapeutic Updates in Ophthalmology and has delivered over 300 invited lectures and authored over 60 medical journal articles, book chapters, books, etc. He was trained at Harvard Medical School and the University of Michigan.

Richard H. Guy, Ph.D., Professor of Pharmaceutical Sciences at the University of Bath and is also an Adjunct Professor of Biopharmaceutical Sciences at UCSF and of Pharmaceutical Sciences at the University of Geneva. Dr. Guy's principal achievements have been made in the areas of skin barrier function characterization, transdermal drug delivery, enhancement of percutaneous absorption, iontophoresis, noninvasive biosensing of blood glucose and other analytes, and the prediction and assessment of skin penetration and topical bioavailability. In total, Dr. Guy has published more than 200 peer-reviewed articles and over 70 book chapters. He has co-edited 7 books and is co-author of a recently published text. He is also co-inventor of 10 patents. He was the first recipient of the Controlled Release Society's Young Investigator Award in 1988, the same year that he won the British Pharmaceutical Conference Science Award. Dr. Guy was awarded, for his work in "reverse iontophoresis" and noninvasive glucose monitoring, the Prix Applications Médicales de l'Electricité, 1997 by the Institut Electricité Santé, Paris, France. In April 2000, Dr. Guy received the APV (International Association for Pharmaceutical Technology) Research Award for Outstanding Achievements in the Pharmaceutical Sciences. He received his M.A. in Chemistry from Oxford University, and his Ph.D. in Pharmaceutical Chemistry from the University of London

Eric Souied, M.D., Ph.D., Creteil University Eye Clinic, France and President of the Association Against Macular Degeneration in France. He was trained at the University of Paris XII. His major research interests include the genetics of AMD.